File(s) not publicly available
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce
journal contribution
posted on 2022-01-01, 00:00 authored by J Sarris, A Ravindran, L N Yatham, Wolf MarxWolf Marx, J J Rucklidge, R S McIntyre, S Akhondzadeh, F Benedetti, C Caneo, H Cramer, L Cribb, M de Manincor, Olivia DeanOlivia Dean, A C Deslandes, M P Freeman, B Gangadhar, B H Harvey, S Kasper, J Lake, A Lopresti, L Lu, N J Metri, D Mischoulon, C H Ng, D Nishi, R Rahimi, S Seedat, J Sinclair, K P Su, Z J Zhang, Michael BerkMichael BerkClinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce
History
Journal
World Journal of Biological PsychiatryPagination
1 - 32Publisher
Taylor & FrancisLocation
London, Eng.Publisher DOI
ISSN
1562-2975eISSN
1814-1412Language
EnglishPublication classification
C1 Refereed article in a scholarly journalUsage metrics
Read the peer-reviewed publication
Categories
Keywords
ADENOSYL-L-METHIONINEADHDA-DOUBLE-BLINDaffective disordersALTERNATIVE MEDICINE USEATTENTION-DEFICIT\/HYPERACTIVITY DISORDERCREATINE MONOHYDRATE AUGMENTATIONDEFICIT HYPERACTIVITY DISORDERherbal medicinesLife Sciences & BiomedicineMAJOR DEPRESSIVE DISORDERNutrientsPLACEBO-CONTROLLED TRIALPOLYUNSATURATED FATTY-ACIDSPsychiatryschizophreniaScience & TechnologyVITAMIN-D SUPPLEMENTATION